Jaclyn Reynolds, - Counselor in Bellingham, WA

Jaclyn Reynolds, is a Counselor - Mental Health based in Bellingham, Washington. Jaclyn Reynolds is licensed to practice in * (Not Available) (license number ) and her current practice location is 609 N Shore Dr, Bellingham, Washington. She can be reached at her office (for appointments etc.) via phone at (360) 676-6000.

NPI number for Jaclyn Reynolds is 1003227174 and her current mailing address is 609 N Shore Dr, Bellingham, Washington. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1003227174.

Contact Information

Jaclyn Reynolds,
609 N Shore Dr,
Bellingham, WA 98226-4414
(360) 676-6000
Not Available

Healthcare Provider's Profile

Full NameJaclyn Reynolds
GenderFemale
SpecialityCounselor - Mental Health
Location609 N Shore Dr, Bellingham, Washington
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1003227174
  • Provider Enumeration Date: 05/12/2014
  • Last Update Date: 05/12/2014

Medical Identifiers

Medical identifiers for Jaclyn Reynolds such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1003227174NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
101YM0800XCounselor - Mental Health (* (Not Available))Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jaclyn Reynolds is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Jaclyn Reynolds,
609 N Shore Dr,
Bellingham, WA 98226-4414

Ph: () -
Jaclyn Reynolds,
609 N Shore Dr,
Bellingham, WA 98226-4414

Ph: (360) 676-6000

News Archive

Supreme Court to decide crucial case on patenting human genes

The high court will hear a challenge to Myriad Genetics' patent of breast and ovarian cancer genes in a case that will affect the future of biomedical research, the fight against diseases like breast and ovarian cancer and a multi-billion dollar biotechnology business.

Study highlights the importance of bicycle helmets

Bicycle helmets save lives, and their use should be required by law. That's the conclusion of a study to be presented Monday, May 6, at the Pediatric Academic Societies (PAS) annual meeting in Washington, DC.

Constella® (linaclotide), for the symptomatic treatment of Irritable Bowel Syndrome with Constipation (IBS-C), is now available in Germany, UK and Nordic countries

Almirall, S.A. (ALM:MC) and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced the launch of Constella® (linaclotide 290mcg capsules once daily), the first approved prescription therapy in a new class of treatments for adults suffering from moderate to severe IBS-C,(1) in Europe. Constella® is now available in Germany, the UK and Nordic countries and is expected to be launched in several other European countries in 2013.

Riverside Methodist Hospital treats first PAD patient with Cook Medical's Zilver PTX device

Just weeks after the Food and Drug Administration (FDA) approved Cook Medical's Zilver PTX Drug-Eluting Peripheral Stent, Riverside Methodist Hospital in Columbus, Ohio, has treated the first patient with the device as part of Cook's U.S. commercial launch.

Gene therapy effectively stabilizes progression of cerebral adrenoleukodystrophy, trial reveals

In a recent clinical trial, a gene therapy to treat cerebral adrenoleukodystrophy (CALD) - a neurodegenerative disease that typically claims young boys' lives within 10 years of diagnosis - effectively stabilized the disease's progression in 88 percent of patients, researchers from the Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Massachusetts General Hospital report today.

Read more News

› Verified 4 days ago


Counselor in Bellingham, WA

Katharine Margaret Botelle Wolhart, MSW, LICSW
Counselor
Medicare: Not Enrolled in Medicare
Practice Location: 410 W. Bakerview Rd. Suite 110, Office 110, Bellingham, WA 98226
Phone: 360-926-5647    
Mr. Keith Poynter,
Counselor
Medicare: Not Enrolled in Medicare
Practice Location: 2530 Kwina Rd, Bellingham, WA 98226
Phone: 360-384-2330    Fax: 360-384-3218
Mr. Richard J Evans V, MA
Counselor
Medicare: Not Enrolled in Medicare
Practice Location: 600 Lakeway Dr, Bellingham, WA 98225
Phone: 360-676-6749    
Hollace Carole Schetrompf,
Counselor
Medicare: Not Enrolled in Medicare
Practice Location: 609 N Shore Dr, Bellingham, WA 98226
Phone: 360-676-6000    
Ms. Alison Hastings, LMHC
Counselor
Medicare: Not Enrolled in Medicare
Practice Location: 1155 N State St Ste 616, Bellingham, WA 98225
Phone: 360-671-3574    
Julie Nelson, CDP-T
Counselor
Medicare: Not Enrolled in Medicare
Practice Location: 515 Lakeway Dr, Bellingham, WA 98225
Phone: 360-676-2187    Fax: 360-676-2162

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.